Almitas Capital LLC - 30 Sep 2025 SCHEDULE 13G Report for AN2 Therapeutics, Inc. Common Stock and Warrants (ANTX)

Filing Manager: Almitas Capital LLC
Reporting Manager: Almitas Capital LLC
Security: AN2 Therapeutics, Inc. Common Stock and Warrants
Symbol: ANTX
Shares outstanding: 27,467,750 shares
Disclosed Ownership: 1,428,323 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 14 Nov 2025, 19:51:37 UTC
Date of event: 30 Sep 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Almitas Capital LLC	5.2%	1,428,323	1,428,323	0	Ronald Mass	Managing Principal